Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Retatrutide activates GLP-1, GIP, and glucagon receptors, making it a triple agonist and the most receptor-diverse obesity compound currently in clinical development
Are you overweight or obese and concerned about your health
Retatrutide has not received Health Canada approval
To hit a caloric deficit and lose weight, you need to eat fewer calories than you burn
Local clinics are more likely to bill insurance for visits and labs, though medication coverage varies either way
WW shares are in a pullback driven lower by the falling relative strength index (RSI) slipping under the 60-band
US$ 23.86
US$ 27.03
US$ 26.99
US$ 22.99
US$ 23.37
US$ 21.69
US$ 21.07
US$ 28.58
US$ 23.39
US$ 21.21
US$ 29.81
